Journal of Periodontal and Implant Science

Korean Academy of Periodontology (대한치주과학회)
권호 표지
DOI QR코드

DOI QR Code

The expressions of inflammatory factors and tissue inhibitor of matrix metalloproteinase-2 in human chronic periodontitis with type 2 diabetes mellitus

  • Shin, Dong-Seok (Department of Periodontology, Kyungpook National University School of Dentistry) ;
  • Park, Jin-Woo (Department of Periodontology, Kyungpook National University School of Dentistry) ;
  • Suh, Jo-Young (Department of Periodontology, Kyungpook National University School of Dentistry) ;
  • Lee, Jae-Mok (Department of Periodontology, Kyungpook National University School of Dentistry)
  • Published : 2010.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The purpose of this study was to observe and quantify the expression of interleukin-4 (IL-4), interferon-$\gamma$ (IFN-$\gamma$), and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) in the gingival tissue of patients with type 2 diabetes mellitus (DM) and healthy adults with chronic periodontitis. Methods: Twelve patients with type 2 DM and chronic periodontitis (Group 3), twelve patients with chronic periodontitis (Group 2), and twelve healthy individuals (Group 1) were included in the study. Clinical criteria of gingival (sulcus bleeding index value, probing depths) and radiographic evidences of bone resorption were divided into three groups. The concentrations of cytokines were determined by a western blot analysis and compared using one-way ANOVA followed by Tukey's test. Results: The expression levels of IFN-$\gamma$ and TIMP-2 showed an increasing tendency in Groups 2 and 3 when compared to Group 1. On the other hand, the expression of IL-4 was highest in Group 1. Conclusions: The findings suggest that IFN-$\gamma$ and TIMP-2 may be involved in the periodontal inflammation associated with type 2 DM. IL-4 may be involved in the retrogression of the periodontal inflammation associated with type 2 DM.

Keywords

References

  1. Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol 1992;63:322-31. https://doi.org/10.1902/jop.1992.63.4s.322
  2. Liljenberg B, Lindhe J, Berglundh T, Dahlen G, Jonsson R. Some microbiological, histopathological and immunohistochemical characteristics of progressive periodontal disease. J Clin Periodontol 1994;21:720-7. https://doi.org/10.1111/j.1600-051X.1994.tb00793.x
  3. Mealey BL, Ocampo GL. Diabetes mellitus and periodontal disease. Periodontol 2000 2007;44:127-53. https://doi.org/10.1111/j.1600-0757.2006.00193.x
  4. Diabetes and periodontal diseases. Committee on Research, Science and Therapy. American Academy of Periodontology. J Periodontol 2000;71:664-78. https://doi.org/10.1902/jop.2000.71.4.664
  5. Mealey B. Diabetes and periodontal diseases. J Periodontol 1999;70:935-49. https://doi.org/10.1902/jop.1999.70.8.935
  6. Nishimura F, Takahashi K, Kurihara M, Takashiba S, Murayama Y. Periodontal disease as a complication of diabetes mellitus. Ann Periodontol 1998;3:20-9.
  7. Stewart JE, Wager KA, Friedlander AH, Zadeh HH. The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus. J Clin Periodontol 2001;28:306-10. https://doi.org/10.1034/j.1600-051x.2001.028004306.x
  8. Gemmell E, Seymour GJ. Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontol 2000 2004;35:21-41. https://doi.org/10.1111/j.0906-6713.2004.003557.x
  9. Shapira L, van Dyke TE, Hart TC. A localized absence of interleukin-4 triggers periodontal disease activity: a novel hypothesis. Med Hypotheses 1992;39:319-22. https://doi.org/10.1016/0306-9877(92)90056-I
  10. Prontera C, Crescenzi G, Rotilio D. Inhibition by Interleukin-4 of stromelysin expression in human skin fibroblasts: role of PKC. Exp Cell Res 1996;224:183-8. https://doi.org/10.1006/excr.1996.0126
  11. Mullen AC, High FA, Hutchins AS, Lee HW, Villarino AV, Livingston DM, et al. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 2001;292:1907-10. https://doi.org/10.1126/science.1059835
  12. Ukai T, Mori Y, Onoyama M, Hara Y. Immunohistological study of interferon-gamma- and interleukin-4-bearing cells in human periodontitis gingiva. Arch Oral Biol 2001;46:901-8. https://doi.org/10.1016/S0003-9969(01)00057-7
  13. Roberts FA, McCaffery KA, Michalek SM. Profile of cytokine mRNA expression in chronic adult periodontitis. J Dent Res 1997;76:1833-9. https://doi.org/10.1177/00220345970760120501
  14. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem 1997;378:151-60.
  15. Hammani K, Blakis A, Morsette D, Bowcock AM, Schmutte C, Henriet P, et al. Structure and characterization of the human tissue inhibitor of metalloproteinases-2 gene. J Biol Chem 1996;271:25498-505. https://doi.org/10.1074/jbc.271.41.25498
  16. Ryan ME, Ramamurthy S, Golub LM. Matrix metalloproteinases and their inhibition in periodontal treatment. Curr Opin Periodontol 1996;3:85-96.
  17. Goldberg GI, Marmer BL, Grant GA, Eisen AZ, Wilhelm S, He CS. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci U S A 1989;86:8207-11. https://doi.org/10.1073/pnas.86.21.8207
  18. Reynolds JJ, Hembry RM, Meikle MC. Connective tissue degradation in health and periodontal disease and the roles of matrix metalloproteinases and their natural inhibitors. Adv Dent Res 1994;8:312-9.
  19. Joo SD, Lee JM. The comparison of inflammatory mediator expression in gingival tissues from human chronic periodontitis patients with and without type 2 diabetes mellitus. J Korean Acad Periodontol 2007;37(2 Suppl):353-69. https://doi.org/10.5051/jkape.2007.37.Suppl.353
  20. Kim DH, Park EK, Shin HI, Cho JY, Suh JY, Lee JM. Interrelationship of matrix metalloproteinase and TNF-$\gamma$ in human gingiva with chronic periodontitis associated to type 2 diabetes mellitus. J Korean Acad Periodontol 2006;36:409-5. https://doi.org/10.5051/jkape.2006.36.2.409
  21. Cho JY, Xing S, Liu X, Buckwalter TL, Hwa L, Sferra TJ, et al. Expression and activity of human Na+/I- symporter in human glioma cells by adenovirus-mediated gene delivery. Gene Ther 2000;7:740-9.
  22. Park JW, Lee JM. The comparison of IL-6, elastase and $\alpha$1- PI expressions in human chronic periodontitis with type 2 diabetes mellitus. J Korean Acad Periodontol 2007;37(2 Suppl):325-38.
  23. Gamonal J, Bascones A, Acevedo A, Blanco E, Silva A. Apoptosis in chronic adult periodontitis analyzed by in situ DNA breaks, electron microscopy, and immunohistochemistry. J Periodontol 2001;72:517-25. https://doi.org/10.1902/jop.2001.72.4.517
  24. Salmon-Ehr V, Ramont L, Godeau G, Birembaut P, Guenounou M, Bernard P, et al. Implication of interleukin-4 in wound healing. Lab Invest 2000;80:1337-43. https://doi.org/10.1038/labinvest.3780141
  25. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol 1997;15:749-95. https://doi.org/10.1146/annurev.immunol.15.1.749
  26. Gorska R, Gregorek H, Kowalski J, Laskus-Perendyk A, Syczewska M, Madalinski K, et al. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis. J Clin Periodontol 2003;30:1046-52. https://doi.org/10.1046/j.0303-6979.2003.00425.x
  27. Larivee J, Sodek J, Ferrier JM. Collagenase and collagenase inhibitor activities in crevicular fluid of patients receiving treatment for localized juvenile periodontitis. J Periodontal Res 1986;21:702-15. https://doi.org/10.1111/j.1600-0765.1986.tb01508.x

Cited by

  1. Cytokines and Bone-Related Factors in Systemically Healthy Patients With Chronic Periodontitis and Patients With Type 2 Diabetes and Chronic Periodontitis vol.82, pp.8, 2010, https://doi.org/10.1902/jop.2011.100643
  2. Partial‐ and full‐mouth scaling and root planing in type 2 diabetic subjects: a 12‐mo follow‐up of clinical parameters and levels of cytokines and osteoclastogenesis‐rela vol.47, pp.1, 2012, https://doi.org/10.1111/j.1600-0765.2011.01403.x
  3. Expression of Immune-Inflammatory Markers in Sites of Chronic Periodontitis in Patients With Type 2 Diabetes vol.83, pp.4, 2010, https://doi.org/10.1902/jop.2011.110324
  4. Influence of Dyslipidemia and Diabetes Mellitus on Chronic Periodontal Disease vol.84, pp.10, 2010, https://doi.org/10.1902/jop.2012.120366
  5. A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes vol.40, pp.14, 2010, https://doi.org/10.1111/jcpe.12059
  6. A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes vol.84, pp.4, 2010, https://doi.org/10.1902/jop.2013.134005
  7. Local levels of inflammatory mediators in uncontrolled type 2 diabetic subjects with chronic periodontitis vol.41, pp.1, 2014, https://doi.org/10.1111/jcpe.12179
  8. Local inflammatory reactions in patients with diabetes and periodontitis vol.69, pp.1, 2010, https://doi.org/10.1111/prd.12089
  9. Crestal Bone Loss Around Submerged and Non-Submerged Dental Implants in Individuals with Type-2 Diabetes Mellitus: A 7-Year Prospective Clinical Study vol.28, pp.1, 2010, https://doi.org/10.1159/000495111
  10. Levels of Myeloperoxidase and Metalloproteinase-9 in Gingival Crevicular Fluid from Diabetic Subjects with and without Stage 2, Grade B Periodontitis vol.2019, pp.None, 2010, https://doi.org/10.1155/2019/5613514